Glaxosmithkline Patient Access Programs Foundation
- Assets
- $73.5m
- Revenue
- $903.0m
- Investments
- $0.0
- Employees
- 0
- Location
- Philadelphia, PA
- Founding
- 01/2004
- Data as of
- 12/2023
- EIN
- 20-0031992
Organization Overview
Glaxosmithkline Patient Access Programs Foundation is located in Philadelphia, PA. The organization was established in 2004. According to its NTEE Classification (T23) the organization is classified as: Private Operating Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Glaxosmithkline Patient Access Programs Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Glaxosmithkline Patient Access Programs Foundation generated $903.0m in total revenue. This organization has experienced exceptional growth, as over the past 5 years, it has increased revenue by an average of 13.2% each year . All expenses for the organization totaled $903.0m during the year ending 12/2023. While expenses have increased by 13.2% per year over the past 5 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2023
Describe the Organization's Program Activity:
Part 3 - Line 4a
PLEASE SEE STATEMENT 16 FOR PROGRAM LISTING
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Robert Todd Holmes President | 4 | $0 | |
Erin Hufman Beetsch Director | 4 | $0 | |
Enda Wiseman Director | 4 | $0 | |
Uleys Jasper Beard Vice President | 4 | $0 | |
Venel Brown Secretary | 4 | $0 | |
Michelle Burke Director | 4 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Lash Group Inc | 12/30/23 | $19,385,347 |
Pharmacord Llc | 12/30/23 | $955,272 |
Compas Inc | 12/30/23 | $220,181 |
Real Endpoints Llc | 12/30/23 | $101,535 |
Iqvia Inc | 12/30/23 | $271,935 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $902,976,608 |
| Interest on Savings | $0 |
| Dividends & Interest | $0 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $0 |
| Capital Gain Net Income | $0 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $0 |
| Total Revenue | $902,976,608 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $0 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $0 |
| Interest | $0 |
| Taxes | $0 |
| Depreciation | $0 |
| Occupancy | $0 |
| Travel, conferences, and meetings | $0 |
| Printing and publications | $0 |
| Other expenses | $21,046,186 |
| Total operating and administrative expenses | $21,046,186 |
| Contributions, gifts, grants paid | $881,930,422 |
| Total expenses and disbursements | $902,976,608 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $0 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $73,494,202 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $0 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $0 |
| Total assets | $73,494,202 |
| Accounts payable and accrued expenses | $73,494,202 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $73,494,202 |